The Christie NHS Foundation Trust
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 2007-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.christie.nhs.uk/
TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment
- Conditions
- Metastatic Melanoma
- Interventions
- First Posted Date
- 2013-11-26
- Last Posted Date
- 2023-04-20
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 2
- Registration Number
- NCT01995344
- Locations
- 🇬🇧
The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom
MRI in Pre-operative Radiotherapy for Soft Tissue Sarcoma: MISTS Study
- Conditions
- Sarcoma
- Interventions
- Device: MRI scanning
- First Posted Date
- 2013-10-08
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 15
- Registration Number
- NCT01956019
- Locations
- 🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom
NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- Radiation: Radiotherapy
- First Posted Date
- 2013-09-25
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 338
- Registration Number
- NCT01950689
- Locations
- 🇬🇧
Cheltenham General Hospital, Cheltenham, Gloucestershire, United Kingdom
🇬🇧Clatterbridge Centre for Oncology, Bebington, Merseyside, United Kingdom
🇬🇧St James' Hospital, Leeds, West Yorkshire, United Kingdom
Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers
- Conditions
- Ampullary CancerCholangiocarcinomaBiliary Tract CancerGallbladder Cancer
- Interventions
- First Posted Date
- 2013-08-20
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 162
- Registration Number
- NCT01926236
- Locations
- 🇬🇧
Queen Elizabeth Hospital, Birmingham, United Kingdom
🇬🇧Bristol Haematology & Oncology Centre, Bristol, United Kingdom
🇬🇧North Cumbria University Hospitals, Carlisle, United Kingdom
Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy
- Conditions
- SarcomaLymphoma
- Interventions
- Procedure: Biomarker and health economics
- First Posted Date
- 2013-08-14
- Last Posted Date
- 2015-02-04
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 50
- Registration Number
- NCT01921998
- Locations
- 🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom
The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study
- Conditions
- Prostate Cancer
- Interventions
- Device: Endorectal Balloon insertion
- First Posted Date
- 2013-04-30
- Last Posted Date
- 2014-07-30
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 10
- Registration Number
- NCT01842750
- Locations
- 🇬🇧
Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
A Phase I Study of CD19 Specific T Cells in CD19 Positive Malignancy
- Conditions
- CD19 Positive Non-Hodgkin Lymphoma
- Interventions
- Genetic: aCD19z cells, IL2, pre conditioning Cyclophosphamide & Fludarabine
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2023-04-19
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 17
- Registration Number
- NCT01493453
- Locations
- 🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom
Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma
- Conditions
- Follicular Lymphoma
- Interventions
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2019-10-15
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 76
- Registration Number
- NCT01493479
- Locations
- 🇫🇷
Centre Hospitalier Universitaire de Lille, Lille, France
🇫🇷Centre Hospitalier Universitaire de Nantes, Nantes, France
🇫🇷Centre Henri Becquerel, Rouen, France
Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus
- Conditions
- Carcinoma of the Oesophagus
- Interventions
- Radiation: Radical external beam radiotherapy, 50Gy in 25 fractions
- First Posted Date
- 2011-10-27
- Last Posted Date
- 2013-08-19
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 36
- Registration Number
- NCT01460888
- Locations
- 🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom
🇬🇧Southampton General Hospital, Southampton, United Kingdom
Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy
- Conditions
- Bladder Cancer
- Interventions
- Other: Sample Collection
- First Posted Date
- 2011-04-27
- Last Posted Date
- 2021-08-13
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 50
- Registration Number
- NCT01343121
- Locations
- 🇬🇧
The Christie NHS Foundation Trust, Manchester, Gtr Manchester, United Kingdom